Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients

Somatostatin has been extensively studied for the prophylaxis of pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP). However, the results remain controversial. The present retrospective cohort study aimed to investigate the efficacy of pre- and post-ERCP somatostatin admini...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHAO, LI-NA, YU, TAO, LI, CHU-QIANG, LAI, YU, CHEN, QI-KUI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079433/
https://www.ncbi.nlm.nih.gov/pubmed/25009610
http://dx.doi.org/10.3892/etm.2014.1733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079433/
https://www.ncbi.nlm.nih.gov/pubmed/25009610
http://dx.doi.org/10.3892/etm.2014.1733

Ejemplares similares